These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 31210418)

  • 1. Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.
    Takigawa H; Masaki S; Naito T; Yuge R; Urabe Y; Tanaka S; Sentani K; Matsuo T; Matsuo K; Chayama K; Kitadai Y
    Cancer Med; 2019 Aug; 8(9):4370-4379. PubMed ID: 31210418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of endoscopic findings in nine cases of Helicobacter suis-infected gastritis complicated by gastric mucosa-associated lymphoid tissue lymphoma.
    Kadota H; Yuge R; Miyamoto R; Otani R; Takigawa H; Hayashi R; Urabe Y; Oka S; Sentani K; Oue N; Kitadai Y; Tanaka S
    Helicobacter; 2022 Jun; 27(3):e12887. PubMed ID: 35363918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication, and hyperacid environment preference of Helicobacter suis: a clinical study.
    Tsukadaira T; Hayashi S; Ota H; Kobayashi N; Agawa H; Kodaira H; Sekiguchi Y; Matsumoto T; Horiuchi K; Negishi T; Tada T
    BMC Gastroenterol; 2024 May; 24(1):157. PubMed ID: 38720287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Coinfection with Gastric Non-Helicobacter pylori Helicobacter (NHPH) Species in Helicobacter pylori-infected Patients Suffering from Gastric Disease in Beijing, China.
    Liu J; He L; Haesebrouck F; Gong Y; Flahou B; Cao Q; Zhang J
    Helicobacter; 2015 Aug; 20(4):284-90. PubMed ID: 25510739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCR analysis and specific immunohistochemistry revealing a high prevalence of non-Helicobacter pylori Helicobacters in Helicobacter pylori-negative gastric disease patients in Japan: High susceptibility to an Hp eradication regimen.
    Nakamura M; Øverby A; Michimae H; Matsui H; Takahashi S; Mabe K; Shimoyama T; Sasaki M; Terao S; Kamada T; Yanaka A; Iwamoto J; Tanabe S; Tari A; Nasu S; Suzuki H; Yamagata Murayama S
    Helicobacter; 2020 Oct; 25(5):e12700. PubMed ID: 32790220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
    Okiyama Y; Matsuzawa K; Hidaka E; Sano K; Akamatsu T; Ota H
    Pathol Int; 2005 Jul; 55(7):398-404. PubMed ID: 15982214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
    Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
    Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
    Neubauer A; Thiede C; Morgner A; Alpen B; Ritter M; Neubauer B; Wündisch T; Ehninger G; Stolte M; Bayerdörffer E
    J Natl Cancer Inst; 1997 Sep; 89(18):1350-5. PubMed ID: 9308704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
    Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
    J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma?
    Rudolph B; Bayerdörffer E; Ritter M; Müller S; Thiede C; Neubauer B; Lehn N; Seifert E; Otto P; Hatz R; Stolte M; Neubauer A
    J Clin Oncol; 1997 Mar; 15(3):1104-9. PubMed ID: 9060551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
    Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
    Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
    Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY
    J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection.
    O'Rourke JL; Dixon MF; Jack A; Enno A; Lee A
    J Pathol; 2004 Aug; 203(4):896-903. PubMed ID: 15258991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
    Bayerdörffer E; Neubauer A; Rudolph B; Thiede C; Lehn N; Eidt S; Stolte M
    Lancet; 1995 Jun; 345(8965):1591-4. PubMed ID: 7783535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
    Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
    Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
    Hiyama T; Haruma K; Kitadai Y; Ito M; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Sumii K; Shimamoto F; Chayama K
    Int J Oncol; 2001 Jun; 18(6):1207-12. PubMed ID: 11351252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
    Miki H; Kobayashi S; Harada H; Yamanoi Y; Uraoka T; Sotozono M; Ohmori M
    J Gastroenterol; 2001 Feb; 36(2):121-4. PubMed ID: 11227668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.